Your browser doesn't support javascript.
loading
Inhibition of DNA synthesis in human gliomas by roscovitine.
Yakisich, J S; Boethius, J; Lindblom, I O; Wallstedt, L; Vargas, V I; Sidén, A; Cruz, M H.
Affiliation
  • Yakisich JS; Applied Biochemistry, Clinical Research Center, Huddinge, Sweden.
Neuroreport ; 10(12): 2563-7, 1999 Aug 20.
Article in En | MEDLINE | ID: mdl-10574370
ABSTRACT
The early effect of 1-100 microM roscovitine, a purine analogue and cyclin-dependent kinase inhibitor, was studied on tissue specimens from eight human malignant gliomas. The tissue was incubated immediately after resection with DMEM containing [3H]methylthymidine plus vehicle alone or the proper concentration of roscovitine for 30-90 min. The DNA synthesis rate was assessed by measurement of [3H]methylthymidine incorporation into trichloroacetic acid insoluble material/mg protein/min. In all gliomas, 100 microM roscovitine inhibited DNA synthesis by 71-97% (average 89 +/- 8%, p<0.0001). This inhibitory effect of roscovitine appeared within 30 min of incubation and was concentration dependent.
Subject(s)
Search on Google
Database: MEDLINE Main subject: Purines / DNA, Neoplasm / Glioblastoma / Antineoplastic Agents Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Year: 1999 Type: Article
Search on Google
Database: MEDLINE Main subject: Purines / DNA, Neoplasm / Glioblastoma / Antineoplastic Agents Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Year: 1999 Type: Article